Legend Biotech Corp (LEGN) — Financial Flexibility Index
Legend Biotech Corp (LEGN) has a Financial Flexibility Index of -0.12x as of December 2025. Free cash flow of $-84.73 Million (operating CF $-105.64 Million minus capex $20.92 Million) represents 0% of total liabilities ($723.60 Million). Also explore net asset growth rate of Legend Biotech Corp to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Legend Biotech Corp Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Legend Biotech Corp across 9 annual periods. Check Legend Biotech Corp (LEGN) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Legend Biotech Corp (2017–2025)
Year-by-year free cash flow to debt coverage for Legend Biotech Corp. For the full company profile including market capitalisation, see Legend Biotech Corp stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.05x | $-32.89 Million | $-100.47 Million | $723.60 Million | ▲ +78.0% |
| 2024 | -0.21x | $-129.93 Million | $-144.03 Million | $629.61 Million | ▲ +66.7% |
| 2023 | -0.62x | $-370.55 Million | $-393.28 Million | $597.24 Million | ▼ -103.3% |
| 2022 | -0.31x | $-179.01 Million | $-201.28 Million | $586.65 Million | ▲ +29.5% |
| 2021 | -0.43x | $-153.06 Million | $-198.47 Million | $353.52 Million | ▲ +72.5% |
| 2020 | -1.58x | $-192.72 Million | $-223.00 Million | $122.27 Million | ▼ -1374.3% |
| 2019 | -0.11x | $-43.90 Million | $-83.06 Million | $410.58 Million | ▼ -113.7% |
| 2018 | 0.78x | $328.70 Million | $307.68 Million | $420.40 Million | ▲ +11995.0% |
| 2017 | -0.01x | $-1.49 Million | $-2.38 Million | $226.53 Million | — |